The lymph nodes were identified by radioimmuno-guided surgery (RIGS) utilising a 125I labelled monoclonal antibody against a mucin expressed by carcinomas, consequently dependent on the presence of tumour cells or tumour-derived material in the nodes. Here, MUC5AC is linked to neoplasm.